BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: Implications for breast- conserving management in patients with BRCA1/BRCA2 mutations

Journal of Clinical Oncology

Volumn 17, Issue 10, 1999, Pages 3017-3024

  Turner, Bruce C ^a   Harrold, Elizabeth ^a   Matloff, Ellen ^a   Smith, Tanya ^a   Gumbs, Andrew A ^a   Beinfield, Malcom ^a   Ward, Brian ^a   Skolnick, Mark ^a   Glazer, Peter M ^a   Thomas, Alun ^a   Haffty, Bruce G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONSERVATIVE TREATMENT; FEMALE; GENE FREQUENCY; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RECURRENCE RISK; SECOND CANCER;

EID: 0032887486     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1999.17.10.3017     Document Type: Article

References (41)

1. Veronesi U, Saccozzi R, Del Vecchio M, et al: Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 305:6-11, 1981
2. Fischer B, Redmond C, Poisson R, et al: Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 820:822-828, 1989
3. Stotter AT, McNeese MD, Ames FC, et al: Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer. Cancer 64:2217-2225, 1989
4. Fischer B, Anderson S, Fischer E, et al: Significance of ipsilateral breast tumor recurrence after lumpectomy. Lancet 338:327-331, 1991
5. Haffty BG, Fischer D, Beinfield M, et al: Prognosis following local recurrence in the conservatively treated breast cancer patient. Int J Radiat Oncol Biol Phys 21:293-298, 1991
6. Haffty BG, Reiss M, Beinfield M, et al: Ipsilateral breast tumor recurrence as a predictor of distant disease: Implications for systemic therapy at the time of local relapse. J Clin Oncol 14:52-57, 1996
7. Haffty BG, Carter D, Flynn SG, et al: Local recurrence versus new primary: Clinical analysis of 82 breast relapses and potential applications for genetic fingerprinting. Int J Radiat Oncol Biol Phys 27:575-583, 1993
8. Turner BC, Haffty BG, Narayanan L, et al: Insulin-like growth factor I receptor overexpression mediates cellular radioresistance and local cancer recurrence after lumpectomy and radiation therapy. Cancer Res 57:3079-3083, 1997
9. Haffty BG, Brown F, Carter D, et al: Evaluation of HER-2 NEU oncoprotein expression as a prognostic indicator of local recurrence in conservatively treated breast cancer: A case-control study. Int J Radiat Oncol Biol Phys 35:751-757, 1996
10. Schnitt SJ, Connolly JL, Harris JR, et al: Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy. Cancer 53:1049-1057, 1984
11. Solin LJ, Fowble BL, Schultz DJ, et al: The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Phys 21:279-287, 1991
12. Kurtz JM, Spitalier JM, Amalric R, et al: Mammary recurrences in women younger than forty. Int J Radiat Oncol Biol Phys 15:271-276, 1998
13. Fowble B, Schultz DJ, Overmoyer B, et al: The influence of young age on outcome in early stage breast cancer. Int J Radiat Oncol Biol Phys 30:23-33, 1994
14. Peterson M, Fowble B, Solin LJ, et al: Family history status as a prognostic factor for breast cancer patients treated with conservative surgery and irradiation. Breast J 1:202-209, 1995
15. Chabner E, Nixon A, Gelman R, et al: Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer. J Clin Oncol 16:2045-2051, 1998
16. Chen LM, Mundt AJ, Powers C, et al: Significance of family history in breast cancer treated with breast conservation therapy. Breast J 2:238-245, 1996
17. Harrold EV, Turner BC, Matloff ET, et al: Local recurrence in the conservatively treated breast cancer patient: A correlation with age and family history. Cancer J Sci Am 4:308-315, 1998
18. McCormick B, Rosen PP, Kinne D, et al: Duct carcinoma in situ of the breast: An analysis of local control after conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 21:289-292, 1991
19. Hiramatsu H, Bornstein B, Recht A, et al: Local recurrence after conservative surgery and radiaton therapy for ductal carcinoma in situ: The possible importance of family history. Cancer J Sci Am 1:55-61, 1995
20. Hall JM, Lee MK, Newman B, et al: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684-1689, 1990
21. Miki Y, Swensen J, Shattuck-Eidens D, et al: A strong candidate for the breast and ovarian cancer suspectibility gene BRCA1. Science 266:66-71, 1994
22. Wooster R, Bignell G, Lancaster J, et al: Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792, 1995
23. Tavtigian SV, Simard J, Rommens J, et al: The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 12:333-337, 1996
24. FitzGerald MG, MacDonald DJ, Krainer M, et al: Germ-line mutations in BRCA1 in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med 334:143-149, 1996
25. Tonin P, Weber B, Offit K, et al: Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 11:1179-1183, 1996
26. Offit K, Gilewski T, McGuire P, et al: Germline BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet 347:1643-1645, 1996
27. Couch FJ, DeShano ML, Blackwood A, et al: BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336:1409-1415, 1997
28. Porter DE, Cohen BB, Wallace MR, et al: Breast cancer incidence, penetrance, and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q 12-21. Br J Surg 81:1512-1515, 1994
29. Shattuck-Eidens D, McClure M, Simard J, et al: A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: Implications for presymptomatic testing and screening. JAMA 273:535-541, 1995
30. Marcus JN, Watson P, Page DL, et al: Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 77:697-709, 1996
31. Schrag D, Kuntz KM, Garber JE, et al: Decision analysis-effects of prophylatic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med 336:1465-1471, 1997
32. Grann V, Panageas K, Whang W, et al: Decision analysis of prophylactic mastectomy and oophorectomy in BrCA1-positive or BRCA2-positive patients. J Clin Oncol 16:979-985, 1998
33. Garcia-Patino E, Gomendio B, Provencio M, et al: Germ-line BRCA1 mutations in women with sporadic breast cancer: Clinical correlations. J Clin Oncol 16:115-120, 1998
34. Lynch HT, Watson P, Conway TA, et al: Clinical/genetic features in hereditary breast cancer. Breast Cancer Res Treat 15:63-71, 1990
35. Johannsson OT, Ranstam J, Borg A, et al: Survival of BRCA1 breast and ovarian cancer patients: A population-based study from southern Sweden. J Clin Oncol 16:397-404, 1998
36. Robson M, Gilewski T, Haas B, et al: BRCA-associated breast cancer in young women. J Clin Oncol 6:642-649, 1998
37. Robson M, Levine D, Brown K, et al: Results of breast conservation therapy (BCT) for invasive breast cancer in women with BRCA mutations. Proc Am Soc Clin Oncol 17:548a, 1998 (abstr 2103)
38. Seynaeve C, v.d.Bosch LMC, Brekelmans CTM, et al: Local recurrence following lumpectomy and irradiation in familial and hereditary vs sporadic breast cancer patients. Proc Am Soc Clin Oncol 17:119a, 1998 (abstr 457)
39. Verhoog LC, Brekelmans CTM, Seynaeive C, et al: Survival and tumor characteristics of breast cancer patients with germline mutations of BRCA1. Lancet 351:316-321, 1998
40. Gaffney DK, Brohet RM, Lewis CM, et al: Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA1 mutations. Radiother Oncol 47:129-136, 1998
41. Shattuck-Eidens D, Oliphant A, McClure M, et al: BRCA1 sequence analysis in women at high risk for susceptibility mutations. JAMA 278:1242-1250, 1997